Peanut threat: oral immunotherapy has its limitations

Stopping therapy risks recurrence of allergic reactions, long-term study finds

Oral immunotherapy for peanut allergy can successfully desensitise patients to high doses of peanut protein, but the protection rapidly declines once treatment stops, a US study has found.